297 related articles for article (PubMed ID: 8763832)
1. The genetics of lantibiotic biosynthesis.
Jack R; Bierbaum G; Heidrich C; Sahl HG
Bioessays; 1995 Sep; 17(9):793-802. PubMed ID: 8763832
[TBL] [Abstract][Full Text] [Related]
2. Unique peptide modifications involved in the biosynthesis of lantibiotics.
Jack RW; Sahl HG
Trends Biotechnol; 1995 Jul; 13(7):269-78. PubMed ID: 7646850
[TBL] [Abstract][Full Text] [Related]
3. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
[TBL] [Abstract][Full Text] [Related]
4. Lantibiotics: insight and foresight for new paradigm.
Nagao J; Asaduzzaman SM; Aso Y; Okuda K; Nakayama J; Sonomoto K
J Biosci Bioeng; 2006 Sep; 102(3):139-49. PubMed ID: 17046525
[TBL] [Abstract][Full Text] [Related]
5. The biology of lantibiotics from the lacticin 481 group is coming of age.
Dufour A; Hindré T; Haras D; Le Pennec JP
FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664
[TBL] [Abstract][Full Text] [Related]
6. Posttranslationally modified bacteriocins--the lantibiotics.
Guder A; Wiedemann I; Sahl HG
Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
[TBL] [Abstract][Full Text] [Related]
7. Post-translational modification of therapeutic peptides by NisB, the dehydratase of the lantibiotic nisin.
Kluskens LD; Kuipers A; Rink R; de Boef E; Fekken S; Driessen AJ; Kuipers OP; Moll GN
Biochemistry; 2005 Sep; 44(38):12827-34. PubMed ID: 16171398
[TBL] [Abstract][Full Text] [Related]
8. Maturation pathway of nisin and other lantibiotics: post-translationally modified antimicrobial peptides exported by gram-positive bacteria.
de Vos WM; Kuipers OP; van der Meer JR; Siezen RJ
Mol Microbiol; 1995 Aug; 17(3):427-37. PubMed ID: 8559062
[TBL] [Abstract][Full Text] [Related]
9. Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes.
Rink R; Kuipers A; de Boef E; Leenhouts KJ; Driessen AJ; Moll GN; Kuipers OP
Biochemistry; 2005 Jun; 44(24):8873-82. PubMed ID: 15952794
[TBL] [Abstract][Full Text] [Related]
10. Genetics of subtilin and nisin biosyntheses: biosynthesis of lantibiotics.
Entian KD; de Vos WM
Antonie Van Leeuwenhoek; 1996 Feb; 69(2):109-17. PubMed ID: 8775971
[TBL] [Abstract][Full Text] [Related]
11. Comparison of lantibiotic gene clusters and encoded proteins.
Siezen RJ; Kuipers OP; de Vos WM
Antonie Van Leeuwenhoek; 1996 Feb; 69(2):171-84. PubMed ID: 8775977
[TBL] [Abstract][Full Text] [Related]
12. New developments in lantibiotic biosynthesis and mode of action.
Patton GC; van der Donk WA
Curr Opin Microbiol; 2005 Oct; 8(5):543-51. PubMed ID: 16118063
[TBL] [Abstract][Full Text] [Related]
13. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.
Martin NI; Sprules T; Carpenter MR; Cotter PD; Hill C; Ross RP; Vederas JC
Biochemistry; 2004 Mar; 43(11):3049-56. PubMed ID: 15023056
[TBL] [Abstract][Full Text] [Related]
14. Quorum sensing control of lantibiotic production; nisin and subtilin autoregulate their own biosynthesis.
Kleerebezem M
Peptides; 2004 Sep; 25(9):1405-14. PubMed ID: 15374644
[TBL] [Abstract][Full Text] [Related]
15. Lantibiotics.
Gasson MJ
Biotechnology; 1995; 28():283-306. PubMed ID: 8688628
[No Abstract] [Full Text] [Related]
16. Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125.
Lawton EM; Cotter PD; Hill C; Ross RP
FEMS Microbiol Lett; 2007 Feb; 267(1):64-71. PubMed ID: 17233677
[TBL] [Abstract][Full Text] [Related]
17. Lantibiotics--unusually modified bacteriocin-like peptides from gram-positive bacteria.
Bierbaum G; Sahl HG
Zentralbl Bakteriol; 1993 Feb; 278(1):1-22. PubMed ID: 8518504
[TBL] [Abstract][Full Text] [Related]
18. Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria.
Sahl HG; Bierbaum G
Annu Rev Microbiol; 1998; 52():41-79. PubMed ID: 9891793
[TBL] [Abstract][Full Text] [Related]
19. NisC binds the FxLx motif of the nisin leader peptide.
Abts A; Montalban-Lopez M; Kuipers OP; Smits SH; Schmitt L
Biochemistry; 2013 Aug; 52(32):5387-95. PubMed ID: 23869662
[TBL] [Abstract][Full Text] [Related]
20. Curvopeptin: a new lanthionine-containing class III lantibiotic and its co-substrate promiscuous synthetase.
Krawczyk B; Völler GH; Völler J; Ensle P; Süssmuth RD
Chembiochem; 2012 Sep; 13(14):2065-71. PubMed ID: 22907786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
